Related Experiment Video
Updated: Feb 23, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Drug delivery approaches for breast cancer
Santosh Kumar Singh1, Shriti Singh2, James W Lillard1
1Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA.
Abstract:
Breast cancer is one of the most common cancers affecting women worldwide. The controlled release of drugs to the precise site of the disease using a nanocarrier vehicle increases the therapeutic efficiency of the drugs. Nanotechnology-based approaches used to endorse clinical improvement from a disease also help to understand the interaction of malignant cells with their microenvironment. Receptor-based targeting is another approach for drug delivery which is undergoing clinical trials. Nanoparticles (NPs) delivery has been proven to promise high loading capacity, less toxicity, and stability of the drugs or biomolecules compared to traditional chemotherapeutic drugs. The goal of this review is to present the current problems of breast cancer therapy and discuss the NP-based targeting to overcome the hurdles of conventional drug therapy approach.
Insights
Nanoparticles enhance breast cancer therapy by enabling controlled drug release and improving drug stability. This nanotechnology approach offers a promising alternative to traditional chemotherapy, reducing toxicity and increasing treatment efficiency.
Area of Science:
- Oncology
- Nanomedicine
- Drug Delivery Systems
Background:
- Breast cancer is a leading global health concern for women.
- Conventional chemotherapy faces challenges including systemic toxicity and limited efficacy.
- Nanotechnology offers novel strategies to improve cancer treatment outcomes.
Purpose of the Study:
- To review current challenges in breast cancer therapy.
- To discuss nanoparticle-based drug delivery systems for improved breast cancer treatment.
- To highlight receptor-based targeting as an emerging therapeutic strategy.
Main Methods:
- Review of current literature on breast cancer treatment modalities.
- Analysis of nanoparticle properties for drug delivery (loading capacity, stability, toxicity).
- Exploration of receptor-based targeting mechanisms in cancer therapy.
Main Results:
- Nanoparticle drug delivery systems show high loading capacity, enhanced stability, and reduced toxicity compared to traditional chemotherapeutics.
- Nanotechnology aids in understanding cancer cell-microenvironment interactions.
- Receptor-based targeting strategies are progressing in clinical trials.
Conclusions:
- Nanoparticle-based drug delivery presents a significant advancement in overcoming limitations of conventional breast cancer therapies.
- Targeted drug delivery using nanoparticles can improve therapeutic efficiency and patient outcomes.
- Further research and clinical application of nanomedicine hold great promise for breast cancer management.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery Systems: Different Types
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Enteral Route

